These findings collectively suggest that SP100 family members may fulfill crucial roles in the initiation and progression of PAAD, as indicated by their significantly heightened expression levels in PAAD tissues when contrasted with corresponding noncancerous tissues. This evidence concerns the gene SP100 and pancreatic adenocarcinoma.